Cardiol Therapeutics Inc 6-K, filed Apr 26, 2024
Cardiol Therapeutics Inc. (CRDL)
About this 6-K
Cardiol Therapeutics Inc filed this 6-K on April 26, 2024.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2024
Commission File Number: 001-40712
Cardiol Therapeutics Inc.
(Translation of registrant's name into English)
602-2265 Upper Middle Road East, Oakville, Ontario, Canada L6H 0G5
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
[X] Form 20-F [ ] Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ]
SUBMITTED HEREWITH
Exhibits
| Exhibit | Description | |
| 99.1 | Notice of Meeting and Record Date |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
CARDIOL THERAPEUTICS INC. |
|
|
|
(Registrant) |
|
|
|
|
|
|
Date: April 25, 2024 |
By: |
/s/ Chris Waddick |
|
|
|
|
|
|
|
Chris Waddick |
|
|
Title: |
Chief Financial Officer |
April 18, 2024
Filed via SEDAR+
To All Applicable Exchanges and Securities Administrators
Subject: Cardiol Therapeutics Inc. (the "Issuer")
Notice of Meeting and Record Date
Dear Sir/Madam:
We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:
| Meeting Type: | Annual General and Special Meeting |
| Meeting Date: | June 26, 2024 |
| Record Date for Notice of Meeting: | May 13, 2024 |
| Record Date for Voting (if applicable): | May 13, 2024 |
| Beneficial Ownership Determination Date: | May 13, 2024 |
| Class of Securities Entitled to Vote: | Class A Common |
| ISIN: | CA14161Y2006 |
| Issuer sending proxy materials directly to NOBOs: | No |
| Issuer paying for delivery to OBOs: | Yes |
| Notice and Access for Beneficial Holders: | Yes |
| Beneficial Holders Stratification Criteria: | Not Applicable |
| Notice and Access for Registered Holders: | Yes |
| Registered Holders Stratification Criteria: | Not Applicable |
In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.
Yours truly,
Odyssey Trust Company
as agent for Cardiol Therapeutics Inc.